Troponin T mRNA and protein isoforms in the human left ventricle: pattern of expression in failing and control hearts

L Mesnard-Rouiller1, J J Mercadier, G Butler-Browne

  • 1Université de Paris XI-C.N.R.S. ERS 566, Le Plessis Robinson, France.

Insights

Cardiac troponin T (cTnT) isoforms show altered expression in heart failure. While cTnT4 increased in some failing hearts, cTnT1 protein unexpectedly decreased across all samples, suggesting stress-related changes.

Area of Science:

  • Molecular biology
  • Cardiovascular research
  • Protein biochemistry

Background:

  • Human cardiac troponin T (cTnT) exhibits multiple isoforms due to alternative splicing.
  • Previous studies indicated altered cTnT isoform expression in failing hearts, particularly increased cTnT4 and fetal-type splicing products.

Purpose of the Study:

  • To investigate the mRNA and protein expression levels of four cTnT isoforms (cTnT1-4) in failing human ventricles compared to controls.
  • To clarify the role of specific cTnT isoforms in the context of left ventricular failure and cardiac stress.

Main Methods:

  • Quantitative analysis of cTnT mRNA and protein isoforms using RNase protection assays and Western blotting.
  • Comparison of isoform expression in left ventricular tissue from heart transplant recipients (failing hearts) and control subjects.

Main Results:

  • cTnT3 was the predominant mRNA isoform, with cTnT4 as a minor isoform; cTnT1 and cTnT2 were barely detectable.
  • Protein levels generally mirrored mRNA abundance, with cTnT3, cTnT4, and cTnT1 detected.
  • Increased cTnT4 mRNA and protein were observed in only half of failing ventricles, suggesting a stress-related rather than a universal failure characteristic.
  • A significant decrease in cTnT1 protein was consistently observed in all failing ventricular samples compared to controls.

Conclusions:

  • Cardiac troponin T isoform expression is complex, with cTnT3 being the major species.
  • The observed increase in cTnT4 in some failing hearts may be linked to cardiac stress, not necessarily failure itself.
  • A consistent decrease in cTnT1 protein in failing hearts warrants further investigation into its functional implications.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...